These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 16189179

  • 1. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD, Keenan DM, Mielke K, Miles JM, Bowers CY.
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [Abstract] [Full Text] [Related]

  • 2. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD, Evans WS, Bowers CY.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [Abstract] [Full Text] [Related]

  • 3. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C, Miles J, Bowers CY, Veldhuis JD.
    Am J Physiol Regul Integr Comp Physiol; 2013 May 01; 304(9):R712-9. PubMed ID: 23485864
    [Abstract] [Full Text] [Related]

  • 9. Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults.
    Veldhuis JD, Patrie JT, Brill KT, Weltman JY, Mueller EE, Bowers CY, Weltman A.
    J Clin Endocrinol Metab; 2004 Dec 01; 89(12):6291-6. PubMed ID: 15579792
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2290-300. PubMed ID: 15126555
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.
    Soares-Welch C, Farhy L, Mielke KL, Mahmud FH, Miles JM, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2005 Apr 01; 90(4):2225-32. PubMed ID: 15634714
    [Abstract] [Full Text] [Related]

  • 14. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD.
    Eur J Endocrinol; 1998 Jul 01; 139(1):59-71. PubMed ID: 9703380
    [Abstract] [Full Text] [Related]

  • 15. Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.
    Iranmanesh A, Bowers CY, Veldhuis JD.
    Eur J Endocrinol; 2010 Jun 01; 162(6):1043-9. PubMed ID: 20299490
    [Abstract] [Full Text] [Related]

  • 16. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
    Veldhuis JD, Bowers CY.
    Am J Physiol Endocrinol Metab; 2009 May 01; 296(5):E1085-92. PubMed ID: 19240251
    [Abstract] [Full Text] [Related]

  • 17. Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
    Veldhuis JD, Keenan DM, Bowers CY.
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct 01; 293(4):R1514-21. PubMed ID: 17686882
    [Abstract] [Full Text] [Related]

  • 18. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD, Evans WS, Bowers CY.
    J Clin Endocrinol Metab; 2003 Nov 01; 88(11):5484-9. PubMed ID: 14602794
    [Abstract] [Full Text] [Related]

  • 19. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb 01; 86(2):700-12. PubMed ID: 11158034
    [Abstract] [Full Text] [Related]

  • 20. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb 01; 86(2):551-60. PubMed ID: 11158008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.